Maria De Santis to Young Adult
This is a "connection" page, showing publications Maria De Santis has written about Young Adult.
Connection Strength
0.005
-
SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11). Eur J Cancer. 2019 01; 107:37-45.
Score: 0.005